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Plasma membrane PI4P helps determine the identity
of this membrane and plays a key role in signal trans-
duction as the precursor of PI(4,5)P2 and its metabo-
lites. Here, we report the atomic structure of the
protein scaffold that is required for the plasma
membrane localization and function of Stt4/PI4KIIIa,
the PI 4-kinase responsible for this PI4P pool. Both
proteins of the scaffold, Efr3 and YPP1/TTC7, are
composed of a-helical repeats, which are arranged
into a rod in Efr3 and a superhelix in Ypp1. A
conserved basic patch in Efr3, which binds acidic
phospholipids, anchors the complex to the plasma
membrane. Stt4/PI4KIIIa is recruited by interacting
with the Ypp1 C-terminal lobe, which also binds to
unstructured regions in the Efr3 C terminus. Phos-
phorylation of this Efr3 region counteracts Ypp1
binding, thus providing a mechanism through which
Stt4/PI4KIIIa recruitment, and thus ametabolic reac-
tion of fundamental importance in cell physiology,
can be regulated.
INTRODUCTION
Phosphoinositides, the membrane phospholipids that result
from the reversible phosphorylation of the PtdIns inositol ring
at the 3,4, and 5 positions, play a wide variety of regulatory roles
in cell physiology (Di Paolo and De Camilli, 2006). Via their
cytosol-exposed head group, they control interactions of the
bilayer with signaling, cytoskeletal, and trafficking proteins and
with cytosolic regions of integral membrane proteins, thus regu-
lating their activities. Because different phosphoinositides have
different subcellular localization, they help to dictate specific
properties of different membranes and thus are key determi-
nants of membrane identity.
At the plasma membrane, phosphoinositides play an espe-
cially important role because in addition to regulating constitu-
tive functions of the membrane, they are also critical in the trans-
duction of signals from the external world. Key players in
signaling functions are PI4P and its downstream metabolitesDevePI(4,5)P2 and PI(3,4,5)P3, as well as additional metabolites
derived from PI(4,5)P2 via the action of phospholipases and
from PI(3,4,5)P3 via the sequential action of inositol 5-phospha-
tases and 4-phosphatases. PI4P and PI(4,5)P2 are key determi-
nants of plasma membrane identity and participate in nearly
every function associated with this membrane. PI(3,4,5)P3 levels
are very low under basal conditions but are dramatically elevated
in the response to growth factor stimulation so that PI(3,4,5)P3 is
a major regulator of cell motility, protein synthesis, and cell pro-
liferation and consequently plays key roles in the growth and
metastatic dissemination of cancer cells.
Because phosphorylation of PtdIns at the 4 position to
generate PI4P is the first reaction in the generation of all these
signaling metabolites at the plasma membrane, this enzymatic
reaction is particularly important. Thus, the PI 4-kinase complex
that synthesizes PI4P has been implicated in a large number of
cellular processes (Balla and Balla, 2006; D’Angelo et al.,
2008). In yeast, where the complex has been most extensively
studied, these include phosphatidylserine (PS) and sphingolipid
homeostasis (Tabuchi et al., 2006; Trotter et al., 1998), actin
dynamics (Foti et al., 2001), activation of the MAPK pathway
(Audhya and Emr, 2002), and cell-cycle regulation (Muhua
et al., 1998). InDrosophila, a mutation in a PI 4-kinase interaction
partner leads to a paralytic defect at restrictive temperature
(Huang et al., 2004), further underscoring the physiological
importance of plasma membrane PI4P production.
The molecular mechanisms that underlie PI4P synthesis or
its regulation are poorly understood. The PI 4-kinase that cata-
lyzes conversion of PtdIns to PI4P at the plasma membrane,
called PI4KIIIa in mammalian cells and Stt4 in yeast, is part of
a protein complex that is well conserved in eukaryotes (Baird
et al., 2008; Nakatsu et al., 2012). In addition to Stt4/PI4KIIIa,
the complex comprises two other proteins: Efr3 (also known as
‘‘Rolling blackout,’’ or RBO, in Drosophila) and a protein called
Ypp1 in yeast (Baird et al., 2008) and TTC7 in mammals (Nakatsu
et al., 2012). Both proteins are required for the recruitment of
Stt4/PI4KIIIa to the plasma membrane and for its activity (Baird
et al., 2008; Nakatsu et al., 2012), though the basis for plasma
membrane targeting is unknown. In yeast, the PI4K complex is
further organized into patches at the plasmamembrane (Audhya
and Emr, 2002; Baird et al., 2008). Efr3 is required for the plasma
membrane association of the Stt4/PI4KIIIa complex (Baird et al.,
2008; Nakatsu et al., 2012), and Ypp1/TTC7 interacts directly
with both Efr3 and Stt4/PI4KIIIa (Baird et al., 2008; Nakatsulopmental Cell 28, 19–29, January 13, 2014 ª2014 Elsevier Inc. 19
Table 1. Data Collection and Refinement Statistics
Efr3(8–562) Ypp(11–817) Ypp(11–446)
Data Collection
Heavy atom Se Se Se
Space group P 64 2 2 P1 P 21 21 21
Unit cell dimensions
(a, b, c in A˚; a, b,
g in )
136.374, 136.374,
141.143, 90,
90, 120
97.545, 136.65,
154.125, 76.689,
85.673, 72.744
102.345,
129.202,
185.452,
90, 90, 90
Wavelength (A˚) 0.9792 0.9792 0.9792
Resolution (A˚) 29.53–3.20
(3.31–3.20)
25.0–3.25
(3.37–3.25)
30.0–3.04
(3.17–3.04)
Rmerge (%)
a 10.5 (69.1) 11.2 (58.2) 17.3 (77.8)
I/s 23.0 (2.7) 9.2 (1.4) 18.1 (3.9)
Completeness (%) 99.4 (100.0) 98.8 (98.7) 100.0 (100.0)
Redundancy 14.3 (14.3) 2.0 (2.0) 13.5 (13.7)
Refinement
Resolution (A˚) 29.53–3.20 25.1–3.25 
No. of unique
reflections
13,197 114,694 
Rwork/Rfree (%)
b 23.11/25.56 23.98/27.72c 
No. of protein atoms 4,326 48,674 
Average B (A˚2) 103.83 79.19 
Rmsd
Bond length (A˚) 0.004 0.004 
Bond angle () 0.738 0.944 
Ramachandran plotd
Allowed
(% residues)
95.8 97.3 
Generously allowed
(% residues)
4.0 2.6 
Disallowed
(% residues)
0.2 0.1 
Numbers in parentheses represent values in the highest resolution shell.
See Figure S1 for representative electron density maps.
aRmerge =
P
h
P
ijI(h)i  < I(h) > j /
P
h
P
iI(h)I.
bR =
P
hjFobs  Fcalcj /
P
hFobs.
cRfree set was chosen by the thin shell method to avoid NCS bias.
dAs defined by Molprobity.
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key roles in the assembly of the Stt4/PI4KIIIa complex and its
targeting to the plasma membrane. Interestingly, in human cells
infected by hepatitis C virus (HCV), plasma membrane localiza-
tion of PI4KIIIa is disrupted, and it is directed to the endo-
plasmic-reticulum-associated HCV replication compartment
(Reiss et al., 2011). In addition, its activity is upregulated during
viral infection, suggesting links among assembly, targeting,
and activity of the complex. Beyond HCV, several other viruses
require PI 4-kinase activity during viral infection, suggesting a
general and fundamental connection between viral replication
and PI4P metabolism (Altan-Bonnet and Balla, 2012).
The goal of this study was to understand the mechanisms that
underlie the assembly and membrane targeting of the Stt4/
PI4KIIIa complex and to obtain insights on how assembly at
the plasma membrane may be regulated. To this end, we deter-20 Developmental Cell 28, 19–29, January 13, 2014 ª2014 Elsevier Inmined crystal structures of the proteins responsible for kinase
localization, Efr3 and Ypp1/TTC7, and analyzed how they
interact with each other, Stt4/PI4KIIIa, and membranes. We
focused on the yeast proteins for the ease of genetics-based
functional studies in this organism, which allowed validation of
structural and biochemical findings. We found that an N-terminal
portion of Efr3 (Efr3-N) and Ypp1 both are scaffold proteins
comprising a-helical repeats. In Efr3-N, these repeats are folded
into an elongated rod with a conserved basic patch at one end,
and this patch mediates Efr3 membrane targeting, associating
with acidic phospholipids as enriched in the plasma membrane.
In Ypp1, HEAT-like repeats are arranged into a superhelix. Its
C-terminal half interacts with both Stt4 and unstructured regions
that form the C terminus of Efr3 (Efr3-C), thereby linking Efr3 and
Stt4. The C-terminal portion of Efr3 is highly phosphorylated
in vivo, and its phosphorylation abrogates the interaction with
Ypp1, leading to Stt4 mislocalization and changes in PI4P levels
in vivo. Our findings therefore indicate that assembly of the Stt4/
PI4KIIIa complex at the plasma membrane, and hence its activ-
ity, can be regulated by Efr3 phosphorylation.
RESULTS AND DISCUSSION
Efr3-N Is a Rod of ARM- and HEAT-like Repeats
Although previous reports had proposed a transmembrane orga-
nization for Efr3 (Huang et al., 2004), Efr3 is a peripheral
membrane protein (Nakatsu et al., 2012). Structure predictions
suggested an N-terminal folded module followed by a disor-
dered C-terminal region. Thus, in obtaining crystals, we focused
on an N-terminal fragment from the S. cerevisiae protein (Efr3-
N8–562), and we obtained its structure at 3.2 A˚ resolution. Efr3-
N8–562 was recombinantly expressed in and purified from
E. coli and crystallized in space group P6422 with one molecule
in the asymmetric unit. The single-wavelength anomalous
dispersion method (SAD) with selenomethionine-substituted
crystals was used for phasing. The final model, which includes
residues 9–562 of Efr3-N8–562 except for a disordered loop
comprising residues 217–232, was refined to Rwork = 23.11%
and Rfree = 25.56%with good geometry (Table 1; Figure S1 avail-
able online).
Efr3-N8–562 is entirely a helical, with ARM- and HEAT-like
repeats arranged into an almost straight 120 A˚ long rod (Fig-
ure 1). Helices H1–H8 at the N terminus form a VHS domain, a
mixture of ARM- and HEAT-like repeats, whereas the rest of
Efr3-N8–562 comprises primarily HEAT-like repeats.
Because functionally important surfaces are highly conserved
in evolution, we analyzed and mapped sequence conservation
onto the Efr3-N8–562 structure (Ashkenazy et al., 2010) (Fig-
ure 1B). Two conserved surfaces are present. A small conserved
patch near the middle of the Efr3-N8–562 rod is formed by loops
joining helices H11 and H12, H13 and H14, H15 and H16, and
H17 and H18. Another prominent conserved patch at the
N-terminal end of Efr3-N8–562 is formed by helices H1-H2-H3
of the VHS domain at the tip of the rod.
It is worth noting that although the VHS domain sequence
is the most conserved in Efr3, residues at the surface of H5
and H7 in the VHS domain are not well conserved. This surface
functions in the recognition and binding of dileucine sorting sig-
nals in other characterized VHS domains (Misra et al., 2002;c.
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Figure 1. Structure of Efr3-N
(A) Ribbons diagram, colored blue to red from N terminus to C terminus.
(B) Conservation in Efr3-N. Orientation at left is as in (A). Surfaces around the N terminus of Efr3-N and in the middle of the rod are highly conserved.
(C) Electrostatic potential. The conserved surface at the N terminus is basic.
(D) Location of mutations mapped onto structure. Residues H67 and R69, which are mutated in Efr3-3 and Efr3-N2, are in the conserved basic patch, but not
visible here. Recombinant Efr3-3 is well folded as assessed by CD (Figure S2), but Efr3-4 aggregates in vitro.
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that its H5–H7 surface is unlikely to play a functionally important
role, whether in peptide binding or otherwise.
We prepared yeast strains with mutant Efr3 proteins in which
the conserved surfaces were altered for in vivo studies designed
to assess the functional importance of these surfaces. In Efr3-3,
residues in the prominent patch near the Efr3 N terminus were
mutated (K12A, R46D, K49A, K52A, H67E, and R69A), whereas
in Efr3-4 we altered the residues in the smaller conserved
surface near the middle of Efr3 (V292D, Y296A, S336K, D339A,
K371A, Q377A, and D380A) (Figure 1D). Wild-type or mutant
Efr3, or C-terminally GFP-labeled versions of these proteins,
were introduced into S. cerevisiae by the plasmid shuffling
method (Sikorski and Boeke, 1991), replacing endogenous
Efr3. Because Efr3 is essential (including under growth con-
ditions used here), yeast strains harboring mutations that affect
Efr3 function are expected to grow less well or be inviable.
Indeed, we found that both Efr3-3 and Efr3-4 were growth
impaired as compared to strains with wild-type Efr3 (Figure 2A).
Efr3-3 mutations do not affect protein folding (Figure S2). Note,
however, that because recombinant Efr3-4-N is prone to
aggregation in vitro, we cannot entirely exclude that the Efr3-4
mutations could compromise protein folding or stability. Never-
theless, it is unlikely that the defect is severe in vivo because
only surface residues were mutated, and, moreover, Efr3-4 res-
cues growth under standard conditions (30C) and still localizes
to the plasma membrane correctly (see below).
To directly assess the effect of Efr3 mutations on PI4K activity
in vivo, we compared the cellular levels of PI4P and PI(4,5)P2
and, as a control, PI3P in strains harboring wild-type or mutant
proteins (Figure 2B). Strikingly, the levels of PI4P were reduced
by 30%–40% in the mutant strains, whereas the levels of
PI3P were unaffected. Because the Stt4/PI4KIIIa complex is
responsible for production of approximately half the cellular
PI4P (Audhya et al., 2000; Nakatsu et al., 2012; Yoshida et al.,
1994), this reduction indicates a severe defect in Stt4 function.DeveSomewhat surprisingly, because PI4P is the precursor of
PI(4,5)P2, levels of PI(4,5)P2 were not substantially altered.
Nevertheless, this finding is consistent with previous studies in
mammalian PI4KIIIa knockout cells, showing that cellular levels
of PI(4,5)P2 are maintained, likely as a result of compensatory
production of PI(4,5)P2 by another pathway (Nakatsu et al.,
2012). These experiments confirm that both conserved surfaces
in Efr3-N8–562 are functionally important.
A Basic Surface Patch Is Required to Target Efr3 to the
Plasma Membrane
Efr3 is proposed to target the Stt4/PI4KIIIa complex to the
plasma membrane (Baird et al., 2008; Nakatsu et al., 2012),
and we used fluorescence microscopy to monitor the effect of
the mutations on the localization of Efr3-GFP constructs (Fig-
ure 2C). We found that mutations in the conserved patch near
the middle of Efr3-N8–562 (the Efr3-4 mutant) did not affect
plasma membrane localization or localization to patches on the
plasma membrane, suggesting that the middle patch does not
play a role in the targeting of Efr3 itself. We have not yet been
able to ascribe a function to this conserved region of Efr3, but
we speculate that it may represent a protein-protein interaction
surface. Efr3-N8–562 interacts with neither Ypp1 nor Stt4 in
protein-protein interaction experiments (not shown). However,
previously published immunoprecipitations suggest that inter-
actors of the Stt4 complex remain to be identified (see Figure 5A
in Audhya and Emr, 2002), and the patch near the middle of the
Efr3-N8–562 may mediate interactions with these proteins.
In contrast, mutations in the patch at the tip of the Efr3 rod
(the Efr3-3 mutant) resulted in a near complete loss of plasma
membrane localization, implicating the conserved patch at the
Efr3 N terminus in membrane association. Because the basic
charge of this surface (Figure 1C) suggests a potential interaction
with the acidic cytosolic face of the plasmamembrane, liposome
binding assays were carried out to test whether Efr3-N8–562
associates with negatively charged lipid bilayers directly. In anlopmental Cell 28, 19–29, January 13, 2014 ª2014 Elsevier Inc. 21
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and S3), we found that Efr3-N8–562 associates efficiently with
liposomes containing phosphoinositides (5%) but without a pref-
erence for a specific phosphoinositide. This result suggested
that Efr3 may associate with acidic membranes via nonspecific
electrostatic interactions. Consistent with this, Efr3 also bound
avidly to liposomes containing physiologically relevant concen-
trations of PS (Figures 2E and S3). Additionally, Efr3-GFP local-
ization to the plasma membrane is unaffected in stt4ts, mss4ts,
and pik1ts yeast backgrounds when cellular PI4P and PI(4,5)P2
levels are depleted (not shown). Our data thus suggest that
Efr3 recognizes the plasma membrane because of its enrich-
ment in acidic phospholipids.
To further test this hypothesis, we performed liposome binding
assays using Efr3-N8–562 constructs harboring mutations in the
basic patch: Efr3-N1 (K12A, R46D K49A, and K52A) and Efr3-
N2 (H67E and R69A) (see Figure 1D). Liposome binding was
markedly reduced for the basic patch mutant Efr3-N1 and not
substantially affected for Efr3-N2 (Figures 2E and 2F) so that
residues K12, R46, K49, and K52 define a conserved basic sur-
face important for Efr3 plasma membrane association.
Unlike Efr3 of fungi, Efr3 of higher eukaryotes is N-terminally
palmitoylated, and palmitoylation is required for plasma
membrane association (Nakatsu et al., 2012). To investigate
whether the basic patch, which is conserved in mammalian
Efr3, provides an additional targeting activity, we performed
in vivo localization experiments in mammalian cells similar to
those described above for yeast. Basic patch mutations analo-
gous to those in yeast Efr3-3 were generated in murine
EFR3A-GFP (K50E, R53A, R61E, R68E, and R70E), and GFP
fusions of wild-type and mutant Efr3 were expressed in HeLa
cells. Whereas wild-type EFR3A-GFP localized to the plasma
membrane, as reported in (Nakatsu et al., 2012), the EFR3A
mutant mislocalized to intracellular compartments tentatively
identified as endosomal compartments because of colocaliza-
tion with a PI3P binding probe (mRFP-FYVEHrs domain) (Fig-
ure 2G). Thus, the basic patch of mammalian Efr3 is required
for correct localization to the plasma membrane.
Ypp1 Is a Superhelix of HEAT-like Repeats
Ypp1 from S. cerevisiae was recombinantly expressed in
and purified from E. coli and crystallized in space group P1
with eight copies of Ypp1 in the unit cell. To obtain diffraction
quality crystals, ten residues at both the N terminus and in a
poorly conserved loop (residues 732–741) were deleted in theFigure 2. Conserved Surfaces in Efr3-N Are Important for Function
(A) Yeast strains with Efr3 mutants are growth impaired as compared to those w
(B) Cellular phosphoinositide levels in wild-type and Efr3 mutant strains. PI4P lev
bars are SD.
(C) Localization of Efr3-GFP constructs in yeast and quantitation. Membrane local
Student’s t test was used to calculate p values.
(D) Liposome binding assays. Experiments shown are sedimentation assays ca
nositide-containing liposomes, though nonspecifically. Similar results were obta
(E) Efr3 also associates with liposomes containing phosphatidylserine, which co
residues (K12A, R46D, K49A, and K52A) in the conserved basic patch are muta
residues (H67E and R69A) is altered.
(F) Binding to phosphoinositide-containing liposomes is significantly reduced for
(G) Murine EFR3A-GFP and the basic-patch mutant EFR3A-3-GFP were express
mRFP-Fyve and does not go to the plasma membrane like wild-type protein.
Devecrystallization construct. We determined the structure of the
selenomethionine-substituted protein at 3.25 A˚ resolution by a
combination of the SAD and molecular replacement methods,
as described in more detail in the Experimental Procedures
section. The N-terminal portion of Ypp1 (Ypp1-N11–446, encom-
passing residues 11–446), for which we had independently
determined the structure, was used as the search model in
molecular replacement. We were able to model all eight Ypp1
copies within the unit cell. The most complete Ypp1 structure
comprises residues 12–817, except for disordered loops span-
ning residues 131–134, 470–483, 714–741, and 788–790. Resi-
dues in several additional loops (residues 608–617, 661–666,
and 680–683) could not be modeled in some of the other Ypp1
moleculeswithin the unit cell. The structurewas refined toRwork =
23.98% and Rfree = 27.72% with good geometry (Table 1;
Figure S1).
Ypp1 forms a dumbbell-like structure95 A˚ long and45 A˚ in
diameter. Like Efr3-N8–562, it consists primarily of HEAT-like
repeats (helices H1–H34), in this case arranged into a superhelix
(Figure 3) rather than a rod. The very C terminus (residues 806–
817 marked by * in Figure 3) is inserted into the center of the
Ypp1 superhelix. As has been observed in other superhelical
proteins (Conti et al., 2006), Ypp1 is inherently flexible with
conformational differences among independent copies in the
crystal (Figure S4). Nevertheless, the first 500 residues superim-
pose well, with root-mean-square deviations (rmsd) in the
carbon-alpha positions ranging from 0.33 A˚ to 0.43 A˚. The super-
position is poorer at the C-terminal end (residues 501–817), and
the rmsd values are higher, between 0.30 A˚ and 0.73 A˚.
To identify functionally important surfaces, we analyzed
and mapped sequence conservation onto the Ypp1 structure
(Figure 3B) (Ashkenazy et al., 2010). The C-terminal half of
Ypp1 is generally well conserved, and there are several promi-
nent conserved surfaces in this portion of the protein, whereas
conservation is poorer in Ypp1-N11–446, which has only a single
conserved surface. None of these surfaces are basic, suggesting
that Ypp1 does not interact directly with the acidic plasma
membrane. Most likely, the conserved surfaces mediate inter-
actions with other complex members or binding partners of the
Stt4 complex, as explored below.
To assess the functional importance of the conserved sur-
faces, we generated Ypp1 constructs with mutations in the
N-terminal conserved surface (Ypp1-dN: F255A, F303A,
Q304A, and N342A) or with C-terminal deletions (D447–817,
D726–817, and D806–817) and tested whether these constructsith wild-type protein.
els are reduced by 30%–40% in the Efr3-3, Efr3-4, and Efr3-DC mutants. Error
ization is reduced for Efr3-3, which hasmutations in the conserved basic patch.
rried out in triplicate; error bars represent SD. Efr3 associates with phosphoi-
ined using flotation assays (Figure S3).
mprises 30% of the plasma membrane. Binding is reduced in Efr3-N1 when
ted, but not in Efr3-N2, in which a different and smaller subset of basic patch
Efr3-N,1 but not Efr3-N2.
ed in HeLa cells. EFR3A-3 colocalizes with the endosomal/lysosomal marker
lopmental Cell 28, 19–29, January 13, 2014 ª2014 Elsevier Inc. 23
Figure 3. Ypp1 Is a HEAT-Repeat Superhelix
(A) Ribbons diagram, colored blue to red from the N terminus to the C terminus. The very C terminus is inserted into the center of the Ypp1 spiral and is marked
with *. See also Figure S4.
(B) Surface conservation, with orientation as in (A).
(C) At left, C-terminal deletions in Ypp1 and residues that were mutated in Ypp1-dN are indicated. In middle, wild-type Ypp1 and Ypp1-dN, but not C-terminally
truncated Ypp1 constructs, can rescue Ypp1 null yeast strains. At right, Ypp1-dN has a growth defect at restricted temperature. (See Figure S2 for CD profiles of
Ypp1 mutants.)
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growth defect at restrictive temperature but are nevertheless
able to rescue Ypp1 null alleles (Figure 3C). In contrast, the
Ypp1 constructs with C-terminal deletions were not able to
rescue Ypp1 null strains, suggesting that the C-terminal portion
of Ypp1 is critical for function (Figure 3C), as explored further
below.
Ypp1 Binds Stt4 via Its C-Terminal Lobe
Ypp1 binds both Stt4 and Efr3, thereby localizing Stt4 to the
plasma membrane (Baird et al., 2008). We confirmed and further
characterized the interaction between Ypp1 and Stt4, first using
size-exclusion chromatography with purified recombinant pro-
teins to estimate the stoichiometry of the Ypp1:Stt4 assembly
(Figure 4A). Hexahistidine-tagged Ypp1 by itself elutes as a
monomer, but when it wasmixedwith FLAG-tagged Stt4 to allow
for complex formation, it elutes in a fraction corresponding to an
440 kDa globular protein. The elution profile suggests a 1:1,
1:2, or 2:1 Stt4:Ypp1 ratio and does not support that Stt4/
Ypp1 complexes associate into larger arrays as previously pro-
posed (Baird et al., 2008).24 Developmental Cell 28, 19–29, January 13, 2014 ª2014 Elsevier InNext, to determine which portion of Ypp1 mediates the inter-
action with Stt4, we used pull-down experiments with gluta-
thione-S-transferase (GST)-tagged Ypp1 constructs as the
‘‘bait’’ and FLAG-tagged Stt4 as the ‘‘prey.’’ FLAG-tagged Stt4
was expressed in HEK293T cells, and lysates from these cells
were used as starting material for the pull-down. Stt4 was
retained by the Ypp1 crystallization construct (residues 11–
817) and to a lesser extent by the C-terminal truncation construct
Ypp111–725-DC, lacking helices H32–H34 and the C-terminal
peptide (Figure 4B). In contrast, Ypp1-N11–446 and the GST-
only control did not retain Stt4. Thus, the interaction with Stt4
is most likely mediated by one or more of the highly conserved
surfaces in the C-terminal half of Ypp1.Wewere unable to obtain
soluble C-terminal Ypp1 fragments and therefore could not test
for interactions between these and Stt4.
Interactions between C-Terminal Portions of Ypp1 and
Efr3 Are Required for Stt4 Plasma Membrane
Recruitment
We also used biochemical experiments to determine how Efr3
and Ypp1 interact. In these experiments GST-Efr3 constructsc.
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Figure 4. The C-Terminal Portion of Ypp1 Is
Required for Interactions with Stt4 and Efr3
(A) Gel filtration chromatography (Superdex200
10/300) showing elution profiles of affinity-purified
FLAG-Stt4 (top panel), His6-Ypp1 (bottom panel),
and a mixture of FLAG-Stt4 and His6-Ypp1 (mid-
dle panels). Stt4 is partially aggregated and mostly
in the void volume, with only a small monodisperse
fraction. Ypp1 alone elutes at 13.75 ml. Its elution
peak shifts in the presence of Stt4, and Ypp1
comigrates with monodisperse Stt4. They elute at
10.8 ml, similarly to the 440 kDa ferritin calibra-
tion standard. The column was calibrated with
HMW calibration standards (Biorad) and ferritin
(Sigma).
(B) Pull-down of recombinant FLAG-tagged Stt4
by purified Ypp1 constructs. Stt4 interacts with
fragments that include C-terminal portions of Ypp1
and not with the N-terminal half of Ypp1.
(C) Pull-down of Ypp1 by C-terminal fragments
of Efr3. Ypp1 interacts with an Efr3 fragment
including residues 651–730.
(D) Pull-down of Ypp1 constructs by an Efr3
C-terminal fragment. Only fragments that include
C-terminal portions of Ypp1 interact with Efr3;
Ypp1-N does not.
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interaction was detected between the Efr3-N8–562 fragment
used for crystallization and Ypp1, as expected from a previous
report that Ypp1 binds the C-terminal half of Efr3 (residues
340–782) (Baird et al., 2008). Because this C-terminal region
of Efr3 is predicted to be mostly random coil, it was subdivided
into three smaller fragments (residues 353–650, 651–730,
and 731–782), which were used as GST baits to more narrowly
identify the binding site for Ypp1. We found that Ypp1 interacts
with Efr3-C651–730, but not with other fragments tested (Fig-
ure 4C). Additionally, we found that Ypp1-N11–446 does not
bind Efr3-C651–730 (Figure 4D), strongly suggesting that the
conserved surface patches in the C-terminal half of Ypp1
mediate interactions with both Efr3 and Stt4. Although the
conserved surface at the Ypp1 N terminus is also likely to be a
protein-protein interaction surface, we have not yet identified
an interaction partner for it.
To probe the importance of the Efr3 C-terminal region for Stt4-
complex function in living cells, we generated yeast strains in
which endogenous Efr3 was replaced by a C-terminally trun-
cated version of the protein, Efr3-DC1–650, or its GFP-tagged
form. Growth of the Efr3-DC1–650 mutant was impaired (Fig-
ure 2A), and cellular PI4P levels were significantly reduced
(by 30%) (Figure 2B), indicating an important role for the
C-terminal region of Efr3 in Stt4-complex function in vivo. As
assessed by fluorescence microscopy, GFP-tagged Efr3-
DC1–650 localized to the plasma membrane, consistent with a
role of its N-terminal basic patch in this localization (Figure 5A).
Interestingly, however, it was more diffusely distributed along
the membrane than the wild-type protein, suggestive of a role
for Efr3 in the organization of patches. Importantly, ectopically
expressed GFP-Stt4 had an entirely cytosolic distribution in
strains expressing Efr3-DC1–650, whereas it was localized to
the plasma membrane and in patches in the presence of wild-
type Efr3 (Figure 5B). These experiments corroborate a modelDeveaccording to which the assembly of the Stt4 complex at the
plasma membrane requires binding of the C-terminal region of
Efr3 (residues 651–782) to Ypp1.
Phosphorylation of the Efr3 C Terminus Modulates Stt4
Complex Assembly
A variety of cellular stresses result in increased production
of PI4P by Stt4 (Audhya and Emr, 2002; Jesch et al., 2010), lead-
ing to the proposal that Stt4 complex activity is regulated.
Interestingly, database searches (http://www.phosphogrid.org)
revealed that the poorly structured C-terminal tail of Efr3 is heavi-
ly phosphorylated, withmore than 20 annotated phosphorylation
sites. Four of these (S681, S684, T687, and T690) are in the highly
conserved region in Efr3 containing the binding site for Ypp1. To
test whether phosphorylation of these residues affects the Efr3/
Ypp1 interaction, pull-down experiments similar to those
described earlier were repeated with GST-Efr3651–730 constructs
in which either the serine or threonine residues were replaced
by glutamate, a mimetic for their phosphorylated form.We found
that either double mutation (S681E/S684E or T687E/T690E)
substantially weakens the interaction between Ypp1 and Efr3-
C651–730 (Figure 5C), supporting the notion that Efr3 phosphory-
lation interferes with the Ypp1/Efr3 interaction. As Efr3 recruits
Ypp1 to the membrane, which in turn recruits Stt4, abrogation
of the Ypp1/Efr3 interaction is expected to interfere with Stt4
activity at the plasma membrane. That is, our result predicts
that Efr3 phosphorylation modulates Stt4 complex assembly
and activity.
To test this hypothesis directly, in vivo experiments were
carried out. We generated an Efr3 mutant, Efr3-43Glu, in which
S681, S684, T687, and T690 at the C terminus were altered to
glutamate, and expressed it as the sole copy of Efr3 in the cell.
Efr3-43Glu-GFP localized to the plasma membrane, and its
distribution phenocopied that of Efr3-DC (Figure 5A). When
GFP-Stt4 was expressed in these cells, a large fraction of Stt4lopmental Cell 28, 19–29, January 13, 2014 ª2014 Elsevier Inc. 25
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Figure 5. Efr3 C-Terminal Phosphorylation Modulates the Efr3-Ypp1
Interaction and Stt4 Complex Assembly
(A) Efr3-DC-GFP localizes to the plasmamembrane in yeast, but does not form
punctae like wild-type Efr3-GFP. The Efr3-43Glu mutant has a similar
phenotype.
(B) GFP-Stt4 is mostly cytosolic when expressed in a Efr3-DC background and
does not localize to the plasma membrane. Stt4-GFP plasma membrane
localization is also reduced in the Efr3-43Glu background.
(C) Ypp1 pull-down with C-terminal fragments of Efr3 (residues 651–730).
Mutating S681/S684 or T687/T690 to glutamate to mimic their phosphoryla-
tion reduced the interaction between Ypp1 and Efr3.
(D) Cellular PI4P levels are reduced by 10% in yeast strains with Efr3-43Glu
as compared to wild-type protein.
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were reduced by 10% (Figure 5D). Although the reduction
in PI4P level was more modest than that observed with the
Efr3-DC mutant (30%), it nevertheless supports the idea that
Efr3-C phosphorylation partially disrupts a major Ypp1/Stt4
binding site on Efr3. The phosphorylation of other sites in the
C-terminal region of Efr3 may also contribute to complex assem-
bly or disassembly. Thus, our findings suggest that one mecha-
nism by which Stt4/PI4KIIIa complex activity can be modulated
is by regulating complex assembly via phosphorylation of the
Efr3 C terminus.
Concluding Remarks
This study elucidates the mechanisms underlying Stt4/PI4KIIIa
recruitment to the plasma membrane and provides insight
regarding the regulation of this important complex (Figure 6).
We have shown how the a-helical repeat proteins Efr3 and
Ypp1 form a scaffold that serves in Stt4/PI4KIIIa recruitment,
identifying a basic surface at one end of the Efr3-N rod required
for Efr3 plasma membrane association and thus for Stt4
enzymatic action at the membrane. Further, we found that the
unstructured C-terminal portion of Efr3 interacts with the C-ter-
minal half of Ypp1 to localize Ypp1 and with it Stt4 to the plasma
membrane. This interaction is attenuated by Efr3 phosphoryla-
tion, providing a mechanism by which to modulate Stt4/PI4KIIIa
complex assembly and activity. It will be particularly interesting
to determinewhether HCV intervenes in thismechanism to reloc-
alize PI4KIIIa to the HCV replication compartment.
An intriguing feature of the yeast Stt4 complex not yet
addressed is that it is not distributed uniformly along the plasma26 Developmental Cell 28, 19–29, January 13, 2014 ª2014 Elsevier Inmembrane but instead localizes to patches. How such patches
form is unclear. It has been proposed that Ypp1 and Stt4
oligomerize, resulting in a crosslinked network (Baird et al.,
2008). Our data, however, suggest that Ypp1 and Stt4 form a
1:1 or 1:2 heterodimer so that Ypp1-Stt4 interactions are unlikely
to scaffold patch formation. Multimerization may be possible,
however, through Efr3. Its C terminus is predicted to be mostly
unstructured, and it could accommodate binding sites along its
length (over 200 amino acids), making it well suited as a cross-
link. Nevertheless, we favor the explanation that patches form
because Stt4 complexes interact with lipid or protein-based
microdomains, which are themselves enriched at particular sites
along the plasma membrane. It has been suggested that Stt4
complexes form near endoplasmic reticulum-plasmamembrane
contact sites (Baird et al., 2008), and perhaps Stt4 complexes
interact with protein residents of these sites. Whether patch
formation is required for Stt4 function in yeast and whether the
mammalian PI4KIIIa complex also forms patches remain open
questions.
In conclusion, our work here is an important step in under-
standing the architecture and regulation of the Stt4/PI4KIIIa
complex, and it provides a structural-biochemical framework
that will be invaluable in guiding further investigations of an intri-
cate enzyme complex.
EXPERIMENTAL PROCEDURES
Cloning
Coding sequences for Efr3-N (residues 8–562) and Ypp1-N11–446 (residues 11–
446) were cloned into a modified PET28 vector, which introduces an N-termi-
nal dodeca-histidine-SUMO tag. Sequences for full-length Ypp111–817 as well
as Ypp111–817(D732–741), a loop deletion construct missing residues 732–741,
Ypp1-N11–446, and Ypp1111–725 were cloned into a modified pCDF vector,
which has an N-terminal GST tag followed by a Prescission protease cleavage
site. Sequences for an N-terminally hexahistine-tagged version of Ypp111–817
for size-exclusion chromatography (in Figure 4) were cloned into the same
pCDF vector, as were C-terminal fragments of Efr3 for pull-down experiments.
We made mutations in Efr3 and Ypp1 using the QuikChange site-directed
mutagenesis kit (Agilent Technologies).
Protein Expression
Plasmids containing the coding sequences for the Efr3 and Ypp1 constructs
were transformed into E. coli BL21(DE3) cells. The cells were grown to an
optical density (OD600) of 0.7 at 37C, and then shifted to 18C, and protein
expression was induced by addition of 0.5 mM isopropylthio-b-galactosidase.
The cells were harvested 20 hr after induction; transferred to lysis buffer
(20mMTris [pH 8.0 at 21C], 500mMNaCl, 1mmTCEP, and 20mM imidazole)
supplemented with protease inhibitors (Complete EDTA-free, from Roche),
DnaseI (Sigma), and lysozyme (American Bioanalytical); and lysed using a
cell disruptor (Avestin).
Purification
Efr3-N and Ypp1-N were isolated using Ni-NTA resin (QIAGEN). After elution,
we cleaved off the his12-SUMO tags with SUMO protease. Uncleaved protein
was removed by passing the sample over Ni-NTA resin a second time and
collecting the flow through. Protein was further purified by size-exclusion chro-
matography (Superdex200; GE Healthcare) and concentrated to 10 mg/ml.
The buffer for Efr3-N contains 20 mM Tris (pH 8.0 at 21C), 800 mM NaCl,
and 2.5 mM Tris(2-carboxyethyl)phosphine (TCEP); the buffer for Ypp1-N
was identical, except in its salt concentration (150 mM).
Ypp111–817, Ypp111–817(D732–741), and Ypp111–725 were bound toGlutathione-
S-Sepharose 4B resin (GE Healthcare). Their GST tags were removed and the
proteins eluted from the resin by cleavage with Prescission protease. Proteins
were further purified by size-exclusion chromatography in buffer containingc.
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Figure 6. Stt4/PI4KIIIa Targeting to the
Plasma Membrane
(A) A conserved basic patch at the N-terminal end
of Efr3 mediates complex association with the
plasma membrane. The Efr3 C terminus and Stt4/
PI4KIIIa both interact with theC-terminal portion of
Ypp1. As yet, no function has been assigned to
conserved surfaces at the middle of Efr3-N or in
the Ypp1 N-terminal half.
(B) Stt4/PI4KIIIa recruitment to the plasma
membrane is reduced when the Efr3 C terminus
is phosphorylated to interrupt the Efr3-Ypp1
interaction. P indicates that the Efr3 C terminus is
heavily phosphorylated in vivo.
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concentrated to 5 mg/ml.
GST-tagged fragments of Efr3 and Ypp1 for the protein-protein interaction
experiments were eluted from the Glutathione-S-Sepharose resin using gluta-
thione and concentrated. During concentration, buffer was exchanged to one
containing 20 mM HEPES (pH 7.4), 140 mM NaCl, and 0.5 mM TCEP.
Selenomethionine-substituted proteins for structure determination were
prepared similarly to native proteins, according to Doublie, 1997.
Crystallization
Crystals of selenomethionine-substituted Efr3-N (residues 8–562) were grown
by the hanging drop method at 21C by mixing 1.35 ml each of protein solution
andmother liquor (0.08M sodium cacodylate [pH 6.5], 0.16M calcium acetate,
11.5% polyethylene glycol [PEG] 8,000, and 20% glycerol) and 0.3 ml of 0.1 M
EDTA. These crystals belong to space group P6422 (a = b = 136.37 A˚, and c =
141.14 A˚) with one molecule of Efr3-N in the asymmetric unit.
Crystals of selenomethionine-substituted Ypp1-N were obtained at 4C
using a 1:1 ratio of protein and well solution (0.1 M sodium acetate [pH 5.0]
and 1.5 M ammonium tartrate). The crystals belong to space group P212121
(a = 102.35 A˚, b = 129.20 A˚, and c = 185.45 A˚) with four molecules of Ypp1-
N in the asymmetric unit.
Crystals of selenomethionine-substituted Ypp111–817(D732–741) were grown at
16C by mixing equal volumes of protein and well solution (0.1 Bis-Tris
propane [pH 7.5], 0.2M sodium bromide, 19%PEG 3,350, and 20mM taurine).
The crystals belong to space group P1 (a = 97.55 A˚, b = 136.65 A˚, and c =
154.125 A˚; a = 76.69C, b = 85.67C, and g = 72.74C), with eight molecules
in the unit cell, where two sets of four molecules are related by a translation
along the longest axis.
Data Collection and Structure Determination
Crystals were quick-soaked inmother liquor supplemented with 15% ethylene
glycol, loopmounted, and flash-frozen in liquid nitrogen. In all cases, data were
collected at the selenium anomalous edge. Data for Efr3-N were collected at
NSLS beamline X29, and data for Ypp1-N and Ypp111–817(D732–741) were
collected at the NE-CAT beamline 24ID-E at Advanced Photon Source
(APS). The data were integrated and scaled using HKL2000 and Scalepack
(Otwinowski and Minor, 1997) (Table 1).
Structures for Efr3-N and Ypp1-N were solved by the SAD method
(Hendrickson and Ogata, 1997) at 3.2 A˚ and 3.0 A˚ resolution, respectively. Se-
lenium positions were located using SHELX (Sheldrick, 2008), and we used
SHARP (Vonrhein et al., 2007) to calculate phases and for solvent flattening.
Representative electron density for Efr3-N is shown (Figure S1A). We built
models for Efr3-N and Ypp1-N using COOT (Emsley and Cowtan, 2004), and
we refined the model for Efr3-N in PHENIX (Adams et al., 2002), using torsion
angle dynamic, real space, positional, translation/libration/screwmotion, and
individual B-factor refinement options and secondary structure restraints (Ta-
ble 1). We did not refine the Ypp1-Nmodel and used the unrefined structure as
a molecular replacement model for phasing the Ypp111–817(D732–741) structure.
For molecular replacement, we used Phaser (McCoy, 2007), positioning
eight copies of Ypp1-N in the Ypp111–817(D732–741) crystal. We identified sele-Devenium sites using the MR-SAD option in Phaser, as implemented in PHENIX
(Adams et al., 2002), and combined phase information from the partial model
(Ypp1-N) with phases obtained by SAD. The electron density maps were
further improved by noncrystallographic symmetry (NCS) averaging either in
PHENIX (Adams et al., 2002) or else in DM (K. Cowtan, 1994, CCP4 Newsletter
on Protein Crystallography). Based on these maps (representative density is
shown in Figure S1B), we were able to build additional portions of Ypp1.
Several cycles of MR-SAD phase combination, NCS averaging, and model
building were required to finally identify 101 of 136 possible selenium positions
and to build the entire Ypp1 molecule. The model of Ypp1 was refined in
PHENIX similarly to Efr3-N (Table 1) but using NCS restraints.
We used Consurf for conservation analysis (Ashkenazy et al., 2010), Pymol
for rendering structure figures (W.L. DeLano, PyMOL molecular graphics
system [Schrodinger]), and GRASP to calculate electrostatic surface potential
(Nicholls et al., 1991).
Liposome Binding Assays
We made liposomes by suspending lipids (Avanti Polar Lipids; Echelon)
in buffer (20 mM Tris [pH 7.4 at 21C], 150 mM NaCl, and 1 mM TCEP) and
vortexing vigorously. We incubated 100 mg of liposomes with 10 mg protein
in buffer (20 mM Tris [pH 7.4 at 21C], 150 mM NaCl, 1 mM TCEP, and 10%
glycerol) for 15 min at room temperature. The incubation mixture was then
diluted to 2.5% glycerol by adding an equal volume of glycerol-free buffer
(20 mM Tris [pH 7.4 at 21C], 150 mM NaCl, and 1 mM TCEP), allowing sedi-
mentation of liposomes. Liposomes were sedimented by centrifugation at
16,000 g for 15 min at 4C. Protein in the supernatant and the pellet was
analyzed by SDS-PAGE electrophoresis, visualized by staining with Coomas-
sie blue, and quantitated using ImageJ (Abramoff et al., 2004).
Size-Exclusion Chromatography with Ypp1 and Stt4
Hexahistidine-tagged Ypp1 was purified by affinity chromatography and gel
filtration, as described for the Ypp1 crystallization construct. FLAG-tagged
Stt4 was expressed in HEK293T cells and the cells lysed by suspension in
binding buffer (20 mM HEPES [pH 7.4], 150 mM NaCl, 1 mM TCEP, 1%
Triton-X, and protease inhibitor). Cleared cell lysate was applied to ANTI-
FLAG affinity resin (Sigma) and eluted using 3xFLAG peptide (Sigma) in elution
buffer (20 mM HEPES [pH 7.4] and 150 mM NaCl). After elution 1 mM TCEP
and protease inhibitors were added.
His6-Ypp1 and FLAG-Stt4 were individually analyzed by gel filtration (Super-
dex200 10/300; GE Healthcare) in gel filtration buffer (20 mM HEPES [pH 7.4],
150 mM NaCl, 1mM TCEP, and protease inhibitor). The mixture of His6-Ypp1
and FLAG-Stt4 was incubated at 4C for 2 hr before the sample was applied
to the same gel filtration column. The fractions were analyzed by SDS-PAGE
and western blotting using anti-FLAG (Sigma) or anti-HIS antibodies (Sigma).
Protein-Protein Interaction Studies with Ypp1 and Stt4
FLAG-tagged Stt4 was expressed in HEK293T cells by transfection with
Lipofectamine (Invitrogen) according to the manufacturer’s protocol. The cells
were lysed by suspension in binding buffer. GST and GST-tagged Ypp1
constructs were immobilized on glutathione-S-Sepharose beads, whichlopmental Cell 28, 19–29, January 13, 2014 ª2014 Elsevier Inc. 27
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at 4C. The resin was washed three times with binding buffer. Proteins were
eluted with SDS sample buffer and analyzed by SDS-PAGE and western blot-
ting with anti-FLAG antibody (Sigma).
Protein-Protein Interaction Studies with Ypp1 and Efr3-C
GST-tagged fragments of Efr3 or mutated versions (S684E/S687E and T687E/
T690E) were incubated with Ypp1, or fragments thereof, in binding buffer at
4C for 1 hr. After addition of glutathione-S-Sepharose resin (10–15 ml; GE
Healthcare), the mixture was incubated for an additional hour at 4C, and
then washed three times with binding buffer. Bound proteins were eluted
from the beads by SDS sample buffer and analyzed by SDS-PAGE and Coo-
massie blue staining.
Yeast Strains
Yeast strains in which endogenous Efr3 was replaced by Efr3 mutants or wild-
type Efr3 were generated by the plasmid shuffling method (Sikorski and
Boeke, 1991). Briefly, strains BY4741 and BY4742 were mated to generate
a heterozygous diploid strain. The heterozygous diploid EFR3/efr3D::KanMX
strain carrying the pRS416EFR3 (CEN-URA) plasmid was sporulated and
dissected to obtain a haploid efr3D::KanMX strain complemented by plasmid.
Then, pRS415 (CEN-LEU) plasmids carrying either wild-type Efr3, Efr3-GFP, or
mutant versions were transformed into haploid cells, and the CEN-URA
plasmids were removed by selecting transformed cells on 5-fluoroorotic
acid (5-FOA) plates at 30C.
GFP-Stt4 was expressed against the Efr3 background using the pRS416
vector.
Efr3 and Ypp1 constructs similar to those introduced into yeast were recom-
binantly expressed and purified from E. coli and characterized in vitro. Efr3-3-
N8–562 (K12A, R46D, K49A, K52A, H67E, and R69A), Ypp1-dN11–817 (F255A,
F303A, Q304A, and N342A), Ypp1 (11–725), Ypp1 (11–446) migrated asmono-
mers as assessed by gel filtration and are well folded and primarily a helical as
assessed by circular dichroism (Figure S2). Efr3-4-N8–562 (V292D, Y296A,
S336K, D339A, K371A, and D380A) and Ypp1 (11–805) were prone to aggre-
gation, migrating in the void volume of the sizing column (Superdex 200; GE
Healthcare).
Metabolic Labeling
Analysis of cellular phosphoinositide levels was carried out as in Nakatsu et al.
(2012). Briefly, cells in log phase were collected and incubated in inositol-free
medium supplemented with [3H] myo-inositol (Perkin Elmer) at 38C for 1 hr.
Lipid was extracted and loaded onto a Shimadzu Ultrafast Liquid Chromato-
graph coupled to a Beta-RAM RHPLC detector (LabLogic). The identity of
each peak was determined by comparison to known compounds, and the
levels of PI3P, PI4P, and PI(4,5)P2 reported are as a percentage of total detect-
able inositol phospholipid.
Live-Cell Imaging, Yeast
Cells were grown to log phase (OD600 = 0.6), concentrated, and mounted on
a microscope slide in synthetic media. Three-dimensional image stacks
were collected in 0.3 m z increments on a DeltaVision Elite workstation (Applied
Precission Instruments) based on an inverted microscope (IX-70; Olympus)
using a 1003, 1.4 NA oil immersion lens. Images were captured at room
temperature (24C) with a 12-bit charge-coupled-device camera (CoolSnap
HQ; Photometrics) and deconvolved using the iterative-constrained algorithm
and the measured point spread function.
Cortical patch to cytosol intensity ratio and patch density analysis were
carried out as described (Chi et al., 2012). Briefly, the medial z plane from
3D image stacks of large budded cells was used to identify the brightest
cortical patch in a cell, and the intensity of the brightest pixel was divided by
fluorescence from the cell cytosol. A representative background intensity
value (outside the cell) was also subtracted from both patch and cytosolic
intensities before calculating the patch/cytosol ratio (n = 30 cells for each
strain). Patch densities (patches/surface area in mm2) were calculated using
optical z sections and shown as max projections (n = 30 for each strain). All
images, 3D graphs, and data analysis were acquired using Delta Vision Soft-
WoRx 5.5 software.28 Developmental Cell 28, 19–29, January 13, 2014 ª2014 Elsevier InLive-Cell Imaging, Mammalian Cells
HeLa cells were cotransfected with mRFP-FYVE (Hrs) (obtained from H.
Stenmark, Oslo University, Oslo, Norway) and either wild-type EFR3A-GFP
(Nakatsu et al., 2012) or a quintuple basic site mutant of EFR3A-GFP (K50E/
R53A/R61E/R68E/R70E). Twenty-four hours after transfection (using FuGENE
HD according to the manufacturer’s instructions; Promega), live cells were
imaged on an UltraVIEW VoX spinning-disc confocal microscope system (Per-
kinElmer) including an invertedmicroscope (Ti-E Eclipse; Nikon) equippedwith
Perfect Focus, temperature-controlled stage, 14-bit electron-multiplying
charge-coupled-device camera (C9100-50; Hamamatsu Photonics) and spin-
ning disc-confocal scan head (CSU-X1; Yokogawa Corporation of America)
controlled by Volocity software (PerkinElmer). Images were acquired through
a 1003 oil objective (1.4 NA; CFI Plan Apochromat VC). Green fluorescence
was excited with a 488 nm/50 mW diode laser (Coherent) and collected by a
band pass (BP) 527/55 nm filter. Red fluorescence was excited with a
561 nm/50 mW diode laser (Cobolt) and collected by a BP 615/70 nm filter.
Multicolor images were acquired sequentially.
The basic site mutant of EFR3A-GFP (K50E/R53A/R61E/R68E/R70E) was
generated from wild-type EFR3A-GFP (Nakatsu et al., 2012) using three
sequential rounds of site-directed mutagenesis (QuikChange II XL; Agilent
Technologies).ACCESSION NUMBERS
Coordinates and structure factors for Efr3-N and Ypp1 have been deposited in
the Protein Data Bank (IDs 4N5A and 4N5C).SUPPLEMENTAL INFORMATION
Supplemental Information includes four figures and can be found with this
article online at http://dx.doi.org/10.1016/j.devcel.2013.11.012.
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